% | $
Quotes you view appear here for quick access.

Osiris Therapeutics, Inc. Message Board

  • scistats scistats Dec 26, 2012 10:58 AM Flag

    Hunker downs boys. Fiscal cliff, debt ceiling, biosurgery profit, and Prochymal for AMI phase 2 data.

    A combination of these factors will determine where Osiris goes from here. Good AMI data has the potential to trump everything because of the market size and likely early FDA approval if the data is convincing enough to hit the market while simultaneously running a phase 3. Can Osiris afford this in "go it alone" fashion?

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
4.96-0.06(-1.20%)Jul 28 4:00 PMEDT